Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
1977-8-25
pubmed:keyword
http://linkedlifedata.com/resource/pubmed/keyword/Case Studies, http://linkedlifedata.com/resource/pubmed/keyword/Contraception, http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents--therapeutic use, http://linkedlifedata.com/resource/pubmed/keyword/Family Planning, http://linkedlifedata.com/resource/pubmed/keyword/Research Methodology, http://linkedlifedata.com/resource/pubmed/keyword/Studies
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0012-0472
pubmed:author
pubmed:issnType
Print
pubmed:day
27
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
812-3
pubmed:dateRevised
2004-11-17
pubmed:otherAbstract
PIP: A 50-year-old woman with serious rheumatism was effectively treated with a combination administration of high doses of estrogens. Presomen (1st-12th day, 3 times daily at 1.25 mg, 13th-23rd day 0.6 mg) and Primosiston (13th-23rd day, 1 tablet 3 times daily) were used. It was inquired as to whether in regard to this particular hormonal substitution there was a contraindication due to the risk of genital carcinoma, and how long such a treatment could be safely undertaken. In response, the author, on the basis of his own clinical experience, considers that conjugated doses of estrogens are generally well taken. The 1.25 mg of Presomen in the first 12 days is considered to be rather high. The risks which are to be seriously considered through the administration of these type or preparations in women during this period are thromboembolism (adiposia, hyperlipidemia, nicotine abuse, operations, and immoblizations being the primary backgrounds). From time to time examinations must be undertaken and the dosage of estrogens reduced.
pubmed:meshHeading
pubmed:year
1977
pubmed:articleTitle
[Ovulation inhibitors in climacteric].
pubmed:publicationType
Letter, English Abstract